How do I order a 25 mg rectal suppository of Compazine (prochlorperazine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Order Compazine (Prochlorperazine) 25mg Suppository

Order prochlorperazine 25 mg rectal suppository, administer one suppository rectally every 12 hours as needed for breakthrough nausea/vomiting, with a maximum of 3 doses per 24 hours.

Prescription Details

The standard ordering format for Compazine suppositories is straightforward:

  • Drug name: Prochlorperazine (Compazine) 25 mg rectal suppository
  • Dosing: 25 mg PR (per rectum) every 12 hours as needed
  • Maximum frequency: Up to 3 doses per 24 hours 1
  • Quantity: Typically dispense 6-12 suppositories depending on anticipated need

Clinical Context and Indications

Prochlorperazine suppositories are FDA-approved for control of severe nausea and vomiting 2. The 25 mg suppository dose is specifically recommended in multiple NCCN antiemetic guidelines as breakthrough treatment for chemotherapy-induced nausea/vomiting 3, 4, 5.

The rectal route is particularly valuable when:

  • Oral medications cannot be tolerated due to vomiting
  • Rapid onset is needed for breakthrough symptoms
  • Patient preference or clinical situation favors non-oral administration

Evidence-Based Dosing

The 25 mg suppository dose every 12 hours is consistently recommended across multiple high-quality guidelines:

  • NCCN guidelines (2009-2017) specify: "Prochlorperazine 25 mg suppository as needed every 12 h" for breakthrough chemotherapy-induced nausea/vomiting 3, 4, 5
  • American Family Physician guidelines recommend: "25 mg orally or suppository, maximum of three doses per 24 hours" for migraine-associated nausea 1
  • Clinical trial data demonstrates excellent efficacy, with 100% of patients achieving positive outcomes within 2 hours when using 25 mg rectal suppositories for acute migraine 6

Important Safety Considerations

Monitor for extrapyramidal symptoms (EPS), particularly dystonic reactions. The NCCN guidelines recommend having diphenhydramine 25-50 mg available every 4-6 hours if dystonic reactions occur 4. Alternative: benztropine 1-2 mg IV/IM if allergic to diphenhydramine.

Black box warnings include risks of type II diabetes, hyperglycemia, and increased mortality in elderly patients with dementia 4.

Contraindications include CNS depression and concurrent use of adrenergic blockers 1.

Practical Administration Tips

Patients should be counseled on proper suppository insertion technique 7, 8:

  • Remove from refrigerator and allow to reach room temperature if too firm
  • Insert pointed end first into rectum
  • Retain for optimal absorption
  • Wash hands before and after administration

Alternative Dosing Options

While 25 mg suppositories are standard for breakthrough treatment, 10 mg oral or IV dosing every 4-6 hours is an alternative when the rectal route is not preferred 3, 4, 5. However, the suppository formulation provides advantages when oral intake is compromised.

The rectal formulation has demonstrated superior efficacy compared to oral administration in some migraine studies 9, making it a preferred option for severe nausea with vomiting.

References

Guideline

management of the acute migraine headache.

American family physician, 2002

Guideline

antiemesis. clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

Guideline

antiemesis.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Guideline

nccn guidelines insights: antiemesis, version 2.2017.

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

Research

Administering a suppository.

Nursing times, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.